Fallahi Poupak, Ruffilli Ilaria, Giuggioli Dilia, Colaci Michele, Ferrari Silvia Martina, Antonelli Alessandro, Ferri Clodoveo
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Department of Medical, Surgical, Maternal, Pediatric and Adult Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Front Endocrinol (Lausanne). 2017 Oct 3;8:266. doi: 10.3389/fendo.2017.00266. eCollection 2017.
We have reviewed scientific literature about the association of systemic sclerosis (SSc) and thyroid disorders. A high incidence, and prevalence, of new cases of autoimmune thyroiditis (AT) and/or hypothyroidism have been shown in sclerodermic patients (overall in the female gender). An association among a Th1 immune-predominance, low vitamin D levels, and AT have been also shown in SSc patients. Cases of Graves' disease (GD) have been described in SSc patients, too, according with the higher prevalence of thyroid autoimmunity. It has been also shown a higher prevalence of papillary thyroid cancer (PTC), in association with AT, in SSc patients. However, in order to confirm results about GD and thyroid cancer, studies in larger number of patients with SSc are needed. During the follow-up of SSc patients it would be appropriate to monitor carefully their thyroid status. The abovementioned data strongly suggest a periodic thyroid function follow-up in female SSc patients [showing a borderline high (although in the normal range) thyroid-stimulating hormone level, antithyroid peroxidase antibody positivity, and a small thyroid with a hypoechoic pattern], and, when necessary, appropriate treatments. In conclusion, most of the studies show an association among SSc, AT, and hypothyroidism, such as an increased prevalence of TC overall in SSc patients with AT. Only few cases of GD have been also described in SSc.
我们回顾了关于系统性硬化症(SSc)与甲状腺疾病关联的科学文献。硬皮病患者(总体上女性居多)中自身免疫性甲状腺炎(AT)和/或甲状腺功能减退症的新发病例显示出高发病率和患病率。SSc患者中还显示出Th1免疫优势、低维生素D水平与AT之间存在关联。根据甲状腺自身免疫的较高患病率,SSc患者中也有格雷夫斯病(GD)的病例报道。还显示SSc患者中与AT相关的甲状腺乳头状癌(PTC)患病率较高。然而,为了证实关于GD和甲状腺癌的结果,需要对更多SSc患者进行研究。在SSc患者的随访期间,仔细监测他们的甲状腺状况是合适的。上述数据强烈表明,对于女性SSc患者[甲状腺刺激激素水平处于临界高水平(尽管在正常范围内)、抗甲状腺过氧化物酶抗体呈阳性且甲状腺较小且呈低回声模式]应定期进行甲状腺功能随访,必要时进行适当治疗。总之,大多数研究表明SSc、AT和甲状腺功能减退症之间存在关联,例如在患有AT的SSc患者中甲状腺癌总体患病率增加。SSc中也仅描述了少数GD病例。